Reduced-intensity conditioning regimen with fludarabine/melphalan versus sequential melphalan, fludarabine and total body irradiation conditioning in acute myeloid leukemia patients with active leukemia or measurable residual disease

被引：0
|
作者：
Lindner, S. [1 ]
Lohmeyer, J. [1 ]
Schlipfenbacher, V. [1 ]
Nguyen, N. T. T. [1 ]
Weber, B. [1 ]
Toenges, R. [1 ]
Riemann, J. [1 ]
Pfeifer, H. [1 ]
Ajib, S. [1 ]
Berg, T. [1 ]
Lang, F. [1 ]
Martin, H. [1 ]
Serve, H. [1 ]
Bug, G. [1 ]
机构：
[1] Univ Klin Frankfurt, Frankfurt, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P992
引用
收藏
页码：282 / 282
页数：1
相关论文
共 50 条
  • [21] Matched Cohort Analysis of Allogeneic Hematopoietic Cell Transplantation (HCT) with Total Marrow Irradiation/Fludarabine/Melphalan (TFM) Versus Fludarabine/Melphalan (FM) Conditioning for Acute Leukemia
    Rosenthal, Joseph
    Wong, Jefrrey
    Stein, Anthony Selwyn
    Stiller, Tracy
    Palmer, Joycelynne
    Forman, Stephen J.
    BLOOD, 2012, 120 (21)
  • [22] Reduced-intensity conditioning with thiotepa, fludarabine and melphalan is an effective regimen for allogeneic transplantation in multiple myeloma
    Majolino, I
    Arana, MG
    Riccardi, M
    Locasciulli, A
    Bacigalupo, A
    Di Bartolomeo, P
    Scimè, R
    Olivieri, A
    Narni, F
    Bregni, M
    De Fabritiis, P
    Musso, M
    Corradini, P
    BONE MARROW TRANSPLANTATION, 2005, 35 : S70 - S70
  • [23] Relationship of iothalamate clearance and NRM in patients receiving fludarabine and melphalan reduced-intensity conditioning
    Kutzke, Jade L.
    Merten, Julianna A.
    Pawlenty, Amanda G.
    Barreto, Erin F.
    Bartoo, Gabe T.
    Mara, Kristin C.
    Litzow, Mark R.
    Hogan, William J.
    V. Shah, Mithun
    Mangaonkar, Abhishek A.
    Leung, Nelson
    Alkhateeb, Hassan B.
    BLOOD ADVANCES, 2022, 6 (13) : 3844 - 3849
  • [24] Reduced-intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma
    Majolino, I
    Arana, MG
    Riccardi, M
    Locasciulli, A
    Bacigalupo, A
    Di Bartolomeo, P
    Scimè, R
    Olivieri, A
    Narni, F
    De Fabritiis, P
    Corradini, P
    BONE MARROW TRANSPLANTATION, 2004, 33 : S37 - S38
  • [25] Fludarabine, Melphalan, and Alemtuzumab Conditioning Regimen in High Risk Leukemia: The Arkansas Experience
    Ravilla, Rahul
    Atwal, Dinesh
    Appalanaidu, Sasapu
    Motwani, Pooja
    Emanuel, Peter
    Jethava, Yogesh
    Veeraputhiran, Muthu
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S295 - S296
  • [26] Correction to: Cord blood transplantation with a reduced-intensity conditioning regimen using fludarabine and melphalan for adult T-cell leukemia/lymphoma
    Nobuaki Nakano
    Yoshifusa Takatsuka
    Ayumu Kubota
    Masahito Tokunaga
    Takayoshi Miyazono
    Tomohisa Tabuchi
    Jun Odawara
    Mayumi Tokunaga
    Torahiko Makino
    Shogo Takeuchi
    Yoshikiyo Ito
    Atae Utsunomiya
    International Journal of Hematology, 2021, 113 : 950 - 950
  • [27] Reduced-intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma
    Majolino, I
    Carnevalli, E
    Locasciulli, A
    Di Bartolomeo, P
    Scimè, R
    Corradini, P
    Selleri, M
    Narni, F
    Musso, M
    Bregni, M
    Olivieri, A
    De Fabritiis, P
    Pogliani, L
    Ruscio, C
    Bacigalupo, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S144 - S145
  • [28] Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioning
    Harada, Kaito
    Yanada, Masamitsu
    Machida, Shinichiro
    Kanamori, Heiwa
    Onizuka, Makoto
    Ozawa, Yukiyasu
    Kobayashi, Hikaru
    Sawa, Masashi
    Katayama, Yuta
    Ohashi, Kazuteru
    Kanda, Junya
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Yano, Shingo
    LEUKEMIA & LYMPHOMA, 2019, 60 (06) : 1493 - 1502
  • [29] Choosing a Reduced-Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation, Fludarabine/Busulfan versus Fludarabine Melphalan: A Systematic Review and Meta-Analysis
    Jain, Tania
    Alandab, Fares
    Firwana, Belal
    Sonbol, Mohamad Bassam
    Almader-Douglas, Diana
    Palmer, Jeanne
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (04) : 728 - 733
  • [30] Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis
    Chichra, Akanksha
    Nayak, Lingaraj
    Kothari, Rushabh
    Kalantri, Siddhesh
    Bonda, Avinash
    Gokarn, Anant
    Punatar, Sachin
    Mirgh, Sumeet
    Jindal, Nishant
    Bagal, Bhausaheb
    Kannan, Sadhana
    Mathew, Libin
    Khattry, Navin
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (01) : 71 - 79
12345